Read the last qtrly burn was $1m but this was offset by $1.2m insurance claim covering the problems with getting the drug ready so NET BURN was 0 in fact cash increased by $150k to $5.68m
Even with a full qtr of salaries cash is unlikely to be much below $5m, $4.5m id guess
They don't need cash for this trial it was initiated at Onyx/Amgens request and they are footing the bill for it
Doubt you'll care about any of these facts but the sad truth is PABs a better buy now at a $2m EV than when you most likely bought with a $40m or $50m EV
Buy the Gloom
Sell the Boom but everyone does the opposite
Ann: Manufacturing Update - Clinical Trial Remains on Hold, page-17
-
- There are more pages in this discussion • 92 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.40M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 5382389 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 2352699 | 1 |
View Market Depth
| Last trade - 16.12pm 02/08/2024 (20 minute delay) ? |
| PAB (ASX) Chart |
Day chart unavailable